RPL32P9

Across TCGA pan-cancer cohorts, RPL32P9 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated RPL32P9 data layer.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher RPL32P9 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RPL32P9 expression acts as an unfavorable survival marker, although some lineages such as SKCM and LAML show a favorable association.

LUSC, ACC, and ESCA are the cancer types where RPL32P9 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	DFS	Tertile	II,III,IV	0.442	0.625	.005	78	view →
ACC	OS	Quartile	All	0.726	0.914	<.001	70	view →
ESCA	OS	Tertile	IV	0.127	0.571	.003	36	view →
READ	OS	Tertile	IV	0.547	0.951	.004	30	view →
DLBC	OS	Tertile	II,III,IV	0.115	0.839	<.001	18	view →
SKCM	OS	Tertile	All	0.922	0.857	.002	15	view →
LAML	DFS	Tertile	All	0.687	0.520	.015	12	view →
PAAD	DFS	Tertile	II,III,IV	0.478	0.237	.034	9	view →
THCA	DFS	Tertile	IV	0.506	0.901	.016	9	view →
LIHC	OS	Tertile	III,IV	0.228	0.551	.016	9	view →
KIRP	OS	Median	III,IV	0.651	0.153	.031	4	view →
BRCA	OS	Tertile	All	0.987	0.959	.030	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

RPL32P9–LUSC (DFS)

Open the LUSC breakdown →